Marker Therapeutics (MRKR) Invested Capital (2010 - 2018)
Marker Therapeutics (MRKR) reported Invested Capital of $695,467 for Q3 2018, down 88.3% from $5.94 million a year earlier and down 83.2% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Invested Capital (2010 - 2018) Analysis & Trends
For FY2017, Marker Therapeutics posted Invested Capital of $3.66 million, down 40.8% from FY2016.
- By year, Invested Capital came in at $6.19 million in FY2016, -$21.33 million in FY2015, -$993,636 in FY2014 and -$5.56 million in FY2013.
- Five-year quarterly Invested Capital spans a low of -$68.08 million in Q2 2015 and a high of $8.57 million in Q2 2017.
- Year over year, Invested Capital has now declined in each of the last five quarters, with an average decline of 57.3% over the last five quarters.
- Per Business Quant data, the three quarters before Q3 2018 came in at $4.15 million (Q2 2018), $620,959 (Q1 2018) and $3.66 million (Q4 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 51.53 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 82.72 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 695,467.00 |
| Jun 30, 2018 | 4.15 Mn |
| Mar 31, 2018 | 620,959.00 |
| Dec 31, 2017 | 3.66 Mn |
| Sep 30, 2017 | 5.94 Mn |
| Jun 30, 2017 | 8.57 Mn |
| Mar 31, 2017 | 4.15 Mn |
| Dec 31, 2016 | 6.19 Mn |
| Sep 30, 2016 | 7.50 Mn |
| Jun 30, 2016 | -19.31 Mn |
| Mar 31, 2016 | -25.68 Mn |
| Dec 31, 2015 | -21.33 Mn |
| Sep 30, 2015 | -27.34 Mn |
| Jun 30, 2015 | -68.05 Mn |
| Mar 31, 2015 | -8.65 Mn |
| Dec 31, 2014 | -993,636.00 |
| Mar 31, 2014 | -5.05 Mn |
| Dec 31, 2013 | -5.19 Mn |
| Sep 30, 2013 | -2.74 Mn |
| Mar 31, 2013 | -2.51 Mn |
API Access
Marker Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();